by Ursula Tschorn | Nov 27, 2025 | Drug Pricing
Executive Summary The global pharmaceutical ecosystem is currently navigating a period of unprecedented complexity. At the epicenter of this environment—balancing the rigorous demands of regulatory compliance, the clinical needs of healthcare professionals, and the...
by Ursula Tschorn | May 12, 2025 | Drug Pricing
Pharmacy wholesale drug prices in Germany are a critical concern for international pharmaceutical wholesalers looking to stay competitive and compliant. Germany is Europe’s largest pharmaceutical market, and its drug pricing system is highly regulated – making market...
by Ursula Tschorn | May 9, 2025 | Drug Pricing
Drug pricing database Germany – these four words sum up a critical need in the pharmaceutical industry. In a market as regulated and dynamic as Germany’s, professionals across market access, pharmacovigilance, hospital pharmacy, and health insurance face the constant...
by Ursula Tschorn | May 9, 2025 | Drug Pricing
Pharmaceutical pricing in Germany is unique in Europe – offering initial free pricing yet governed by strict mechanisms like AMNOG benefit assessments, reference pricing, and rebate contracts. In this comprehensive guide, we explain pharma pricing in Germany for...
by Ursula Tschorn | May 9, 2025 | Drug Pricing
Pharmaceutical market access in Germany is a critical step for any drug developer aiming to tap into Europe’s largest pharmaceutical market. With a population of 84 million and annual pharmaceutical revenues exceeding €56.9 billion in 2021, Germany offers vast...
by Ursula Tschorn | Feb 14, 2019 | Drug Dictionaries, Drug Pricing, Drug Safety, Most popular, News-Updates, Regulatory
The new Falsified Medicines Directive 2019 – which medicines are affected? As of 9. February 2019, the Falsified Medicines Directive (2011/62/EU), which was adopted in 2011, has officially come into force. What does this mean for the affected players such as...
